Freelite aids the detection and monitoring of Multiple Myeloma and related diseases. The Freelite assay is composed of two sensitive and specific immunodiagnostic tests to measure kappa (κ) and lambda (λ) free light chains. It is the only free light chain assay recommended by national and international guidelines
Hevylite allows improved monitoring of Multiple Myeloma patients by more accurate measurement of intact immunoglobulin monoclonal proteins. It is a set of unique laboratory serum tests which overcome some of the problems found using electrophoretic methods, especially when monitoring IgA Multiple Myeloma.